I think we were getting there
TRIUMPH-1 Phase 3 (80 weeks, 12mg, 2,339 patients): 28.3%, with 45.3% achieving 30%
Gastrointestinal side effects: Semaglutide: 20-30% experience significant nausea, especially first 4-8 weeks Tirzepatide: 25-35% experience nausea, often more intense than semaglutide Tirzepatide hits harder
3 ml Syringe : While it also provides precise measurement, it is more suited for larger doses where exact small increments are less critical
Compounded drugs can be important for overcoming shortages or meeting unique patient needsbut compounders should not try to compound drugs in a way that circumvents FDAs approval process." The FDA claims the companies are mass marketing their GLP-1s as similar alternatives to FDA-approved drugs
Many practitioners are now combining CellCore stacking protocols with infrared sauna therapy , ionic detox footbaths, red light therapy, IV nutrient drips , and lymphatic drainage massage for a full-spectrum detox approach